Download presentation
Presentation is loading. Please wait.
Published byAmanda Nyberg Modified over 5 years ago
1
Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort
Florencia Harari, Gerd Sallsten, Anders Christensson, Marinka Petkovic, Bo Hedblad, Niklas Forsgard, Olle Melander, Peter M. Nilsson, Yan Borné, Gunnar Engström, Lars Barregard American Journal of Kidney Diseases Volume 72, Issue 3, Pages (September 2018) DOI: /j.ajkd Copyright © 2018 The Authors Terms and Conditions
2
Figure 1 Overview of the Malmö Diet and Cancer Study (Cardiovascular Cohort) at baseline and follow-up. Abbreviations: CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; Pb, lead; Scr, serum creatinine; Scys, serum cystatin C. American Journal of Kidney Diseases , DOI: ( /j.ajkd ) Copyright © 2018 The Authors Terms and Conditions
3
Figure 2 Incidence of chronic kidney disease (CKD) in relation to blood lead quartiles, adjusted for age, sex, smoking, alcohol intake, hypertension, diabetes mellitus, waist circumference, education level, and estimated glomerular filtration rate (CKD-EPI [CKD Epidemiology Collaboration] creatinine equation) at baseline: (A) quartile 4 (Q4) versus Q1 to Q3 combined, (B) Q2, Q3, and Q4 versus Q1. Number at risk (events) are presented at the bottom of the figure. American Journal of Kidney Diseases , DOI: ( /j.ajkd ) Copyright © 2018 The Authors Terms and Conditions
4
Figure 3 Forest plot of overall and stratified hazard ratios and 95% confidence intervals (CIs) for incident chronic kidney disease (CKD) in relation to quartiles of blood lead at baseline (comparison of quartile 1 [Q1] to Q3 vs Q4), adjusted for age, sex, smoking, alcohol intake, hypertension, diabetes mellitus, waist circumference, education level, and estimated glomerular filtration rate (CKD-EPI [CKD Epidemiology Collaboration] equation) at baseline. American Journal of Kidney Diseases , DOI: ( /j.ajkd ) Copyright © 2018 The Authors Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.